Emfilermin, recombinant human leukemia inhibitory factor (r-hLIF)
Sponsors
Merck KGaA, Darmstadt, Germany
Conditions
Infertility Implantation Failure
Phase 1
r-hLIF for Improving Embryo Implantation in IVF
CompletedNCT00504530
Start: 2001-09-30End: 2002-04-30Updated: 2017-01-04
A Multicentre, Randomised, Double-blind, Placebo-controlled Proof of Concept Study to Compare the Efficacy and Safety of r-hLIF (Emfilermin) for Improving Embryo Implantation Following in Vitro Fertilization (IVF) and Embryo Transfer (ET) in Women With Recurrent Implantation Failure
CompletedNCT00504608
Start: 2003-04-30End: 2004-04-30Updated: 2017-01-04